Lymphoedema
12
4
4
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
Measuring Fluid Buildup in Cancer Patients
Effect of Lymphovenous Anastomosis on Lower Limb Lymphedema: Pragmatic Randomized Controlled Trial
Subclinical Monitoring of Lymphatic Function in Oncology Patients for Lymphoedema Prevention (ONCOLYMPH)
LYT-100 in Patients With BCRL
Spa Therapy for Upper or Lower Limb Lymphoedema
Prospective Observational Lymphoedema Intensive Treatment
Effect of Physical Therapy on Breast Cancer Related Lymphedema
Comparison of Two Types of Bandages in the Treatment of Lymphoedema
A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection
Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema
A Clinical Trial About the Contribution of Manual Lymph Drainage in Complex Physical Therapy for Patients With Lymphoedema Secondary to Mastectomy
Epidemiology and Control of Mansonella Perstans Infection in Uganda